Allogeneic hematopoietic stem cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.

被引:0
作者
Gürman, G [1 ]
Üstün, C [1 ]
Arslan, O [1 ]
Beksaç, M [1 ]
Konuk, N [1 ]
Arat, M [1 ]
Celebi, H [1 ]
Özcan, M [1 ]
Ilhan, O [1 ]
Demirer, T [1 ]
Akan, H [1 ]
Uysal, A [1 ]
Koc, H [1 ]
机构
[1] Ankara Univ, Sch Med, Ibni Sina Hosp, Dept Hematol, TR-06100 Ankara, Turkey
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4509
引用
收藏
页码:350B / 351B
页数:2
相关论文
共 50 条
[21]   Allogeneic Hematopoietic Stem Cell Transplantation in chronic myelogenous leukemia: Comparison of ablative and reduced intensity conditioning regimen. [J].
Gurman, G ;
Arat, M ;
Topcuoglu, P ;
Soydan, EA ;
Ilhan, O ;
Beksac, M ;
Ozcan, M ;
Konuk, N ;
Uysal, A ;
Koc, H ;
Arslan, O ;
Akan, H .
BLOOD, 2003, 102 (11) :471B-471B
[22]   Nonmyeloablative allogeneic hematopoietic stem cell transplantation [J].
Baron, F ;
Beguin, Y .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (02) :243-263
[23]   Allogeneic hematopoietic stem cell transplantation with nonmyeloablative conditioning for patients with chronic lymphocytic leukemia. [J].
Flowers, CR ;
Maloney, DG ;
Sandmaier, BM ;
Shizuru, JA ;
McSweeney, PA ;
Chauncey, TR ;
Niederwieser, D ;
Sahebi, F ;
Agura, E ;
Blume, K ;
Forman, S ;
Storb, R .
BLOOD, 2001, 98 (11) :418A-418A
[24]   Better Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Intensity Conditioning in Elderly Patients with Hematological Malignancies [J].
Zhao, Yongqiang ;
Song, Yanzhi ;
Yang, Fan ;
Li, Feifei ;
Yang, Dongfang ;
Wu, Tong .
BLOOD, 2021, 138
[25]   Second hematopoietic stem cell transplantation using a nonmyeloablative approach: Low toxicity using a fludarabine and intravenous busulfan regimen. [J].
Alyea, EP ;
Kim, HT ;
Fisher, DC ;
Gribben, J ;
Ho, VT ;
Cutler, C ;
Windawi, S ;
Lee, SJ ;
Parik, B ;
Ritz, J ;
Antin, JH ;
Soiffer, RJ .
BLOOD, 2003, 102 (11) :461B-461B
[26]   Nonmyeloablative conditioning and peripheral hematopoietic stem cell grafting in poor-prognosis patients (pts) with hematological malignancies [J].
Hansz, J ;
Gozdzik, J ;
Gil, L ;
Drozdowska, D ;
Sawinski, K ;
Kozlowska-Skrzypczak, M .
BONE MARROW TRANSPLANTATION, 2002, 29 :S147-S148
[27]   Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies [J].
Gürman, G ;
Arat, M ;
Ilhan, O ;
Konuk, N ;
Beksaç, M ;
Çelebi, H ;
Özcan, M ;
Arslan, Ö ;
Üstün, C ;
Akan, H ;
Uysal, A ;
Koç, H .
CYTOTHERAPY, 2001, 3 (04) :253-260
[28]   Treosulfan-based conditioning regimen for allogeneic stem cell transplantation in adult patients with hematological malignancies is non toxic, but not myeloablative [J].
Popova, N. ;
Parovichnikova, E. ;
Kuzmina, L. ;
Vasilyeva, V. ;
Sorokina, T. ;
Drokov, M. ;
Mikhaltsova, E. ;
Koroleva, O. ;
Dubnyak, D. ;
Savchenko, V. .
BONE MARROW TRANSPLANTATION, 2016, 51 :S435-S436
[29]   A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation [J].
G S Hobbs ;
N Kaur ;
P Hilden ;
D Ponce ;
C Cho ;
H R Castro-Malaspina ;
S Giralt ;
J D Goldberg ;
A A Jakubowski ;
E B Papadopoulos ;
C Sauter ;
G Koehne ;
J Yahalom ;
S Delvin ;
J N Barker ;
M-A Perales .
Bone Marrow Transplantation, 2016, 51 :1010-1012
[30]   A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation [J].
Hobbs, G. S. ;
Kaur, N. ;
Hilden, P. ;
Ponce, D. ;
Cho, C. ;
Castro-Malaspina, H. R. ;
Giralt, S. ;
Goldberg, J. D. ;
Jakubowski, A. A. ;
Papadopoulos, E. B. ;
Sauter, C. ;
Koehne, G. ;
Yahalom, J. ;
Delvin, S. ;
Barker, J. N. ;
Perales, M-A .
BONE MARROW TRANSPLANTATION, 2016, 51 (07) :1010-1012